Research Article
Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion
Table 4
Mean and Std deviation of T1 DCE-MRP metrics measured from TM, NNA, and CLNA are given.
| T1 DCE MRP metrics | Mean | Std. Deviation |
| tm ktrans | 0.02 | 0.01 | CLNA ktrans | 0.01 | 0.01 | tm kep | 0.17 | 0.11 | CLNA kep | 2.04 | 1.79 | tm ve | 0.27 | 0.15 | CLNA ve | 0.08 | 0.08 | tm IAUC | 2.83 | 1.30 | CLNA IAUC | 0.41 | 0.36 | tm ktrans | 0.02 | 0.01 | NNA ktrans | 0.01 | 0.01 | tm kep | 0.14 | 0.07 | NNA kep | 1.21 | 0.75 | tm ve | 0.28 | 0.13 | NNA ve | 0.06 | 0.08 | tm IAUC | 2.51 | 0.97 | NNA IAUC | 0.53 | 0.40 |
|
|